These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9600596)

  • 1. Prognostic implication of histopathological, immunohistochemical and clinical features of oligodendrogliomas: a study of 89 cases.
    Dehghani F; Schachenmayr W; Laun A; Korf HW
    Acta Neuropathol; 1998 May; 95(5):493-504. PubMed ID: 9600596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oligodendrogliomas in relation to astrocytes differentiation. Clinicopathologic and immunohistochemical study.
    Tena-Suck ML; Moreno-Jiménez S; Alonso M; Aguirre-Crux L; Sánchez A
    Ann Diagn Pathol; 2008 Oct; 12(5):313-21. PubMed ID: 18774492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors in oligodendroglioma.
    Schiffer D; Dutto A; Cavalla P; Bosone I; Chiò A; Villani R; Bellotti C
    Can J Neurol Sci; 1997 Nov; 24(4):313-9. PubMed ID: 9398978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of cell proliferation, epidermal growth factor receptor, and bcl-2 immunoexpression as prognostic factors for patients with World Health Organization grade 2 oligodendroglioma.
    Reis-Filho JS; Faoro LN; Carrilho C; Bleggi-Torres LF; Schmitt FC
    Cancer; 2000 Feb; 88(4):862-9. PubMed ID: 10679656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathologic study of forty-four histologically pure supratentorial oligodendrogliomas.
    Prayson RA; Mohan DS; Song P; Suh JH
    Ann Diagn Pathol; 2000 Aug; 4(4):218-27. PubMed ID: 10982299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical markers for prognosis of oligodendroglial neoplasms.
    Korshunov A; Golanov A; Sycheva R
    J Neurooncol; 2002 Jul; 58(3):237-53. PubMed ID: 12187958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of a policy of surveillance alone after surgical management of pediatric low grade gliomas.
    Fisher BJ; Leighton CC; Vujovic O; Macdonald DR; Stitt L
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):704-10. PubMed ID: 11597812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclooxygenase-2 in oligodendroglial neoplasms.
    Castilla EA; Prayson RA; Kanner AA; Rybicki LA; Tubbs RR; Vogelbaum MA; Barnett GH
    Cancer; 2003 Oct; 98(7):1465-72. PubMed ID: 14508834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oligodendroglioma: does deferring treatment compromise outcome?
    Feigenberg SJ; Amdur RJ; Morris CG; Mendenhall WM; Marcus RB; Friedman WA
    Am J Clin Oncol; 2003 Jun; 26(3):e60-6. PubMed ID: 12796617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors in children and adolescents with low-grade oligodendrogliomas.
    Bowers DC; Mulne AF; Weprin B; Bruce DA; Shapiro K; Margraf LR
    Pediatr Neurosurg; 2002 Aug; 37(2):57-63. PubMed ID: 12145513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of the proliferation-related antigen Ki-67 in oligodendrogliomas.
    Kros JM; Hop WC; Godschalk JJ; Krishnadath KK
    Cancer; 1996 Sep; 78(5):1107-13. PubMed ID: 8780550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MIB-1 labeling index in astrocytic tumors--a clinicopathologic study.
    Neder L; Colli BO; Machado HR; Carlotti CG; Santos AC; Chimelli L
    Clin Neuropathol; 2004; 23(6):262-70. PubMed ID: 15584210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oligodendroglioma: an analysis of prognostic factors and treatment results.
    Allam A; Radwi A; El Weshi A; Hassounah M
    Am J Clin Oncol; 2000 Apr; 23(2):170-5. PubMed ID: 10776979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oligodendroglioma. The Princess Margaret Hospital experience (1958-1984).
    Nijjar TS; Simpson WJ; Gadalla T; McCartney M
    Cancer; 1993 Jun; 71(12):4002-6. PubMed ID: 8508366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression of cell cycle regulatory proteins in oligodendroglial tumors.
    Kamiya M; Nakazato Y
    Clin Neuropathol; 2002; 21(2):52-65. PubMed ID: 12005253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extent of resection and survival for oligodendroglioma: a U.S. population-based study.
    Kinslow CJ; Garton ALA; Rae AI; Marcus LP; Adams CM; McKhann GM; Sisti MB; Connolly ES; Bruce JN; Neugut AI; Sonabend AM; Canoll P; Cheng SK; Wang TJC
    J Neurooncol; 2019 Sep; 144(3):591-601. PubMed ID: 31407129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of clinical and angiogenesis-related factors in low-grade oligodendrogliomas.
    Vaquero J; Zurita M; Coca S; Oya S; Morales C
    Surg Neurol; 2000 Sep; 54(3):229-34; discussion 234. PubMed ID: 11118569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet-derived growth factor expression correlates with tumor grade and proliferative activity in human oligodendrogliomas.
    Majumdar K; Radotra BD; Vasishta RK; Pathak A
    Surg Neurol; 2009 Jul; 72(1):54-60. PubMed ID: 19559929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Glioneuronal tumor with neuropil-like island: report of four cases and review of literature].
    Duan ZJ; Yao K; Qi XL
    Zhonghua Bing Li Xue Za Zhi; 2016 May; 45(5):324-8. PubMed ID: 27142914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic significance of DNA topoisomerase II-alpha (Ki-S1), p21/Cip-1, and p27/Kip-1 protein immunoexpression in oligodendrogliomas.
    Korshunov A; Golanov A
    Arch Pathol Lab Med; 2001 Jul; 125(7):892-8. PubMed ID: 11419973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.